Market Highlights
It is estimated that the global immunoprecipitation market is expected to hold a market value of USD 562 million and register a CAGR ~ 5.2% during the forecast period of 2018–2023. The method of precipitating a protein antigen from a solution by using an antibody that exactly binds to that particular protein is known as immunoprecipitation. This technique can be used for isolation and concentration of a particular protein from a sample that contains thousands of different proteins. A growing number of research activities in the life sciences sector and rising need to identify antigens associated with autoimmune diseases are driving the market growth. According to a report published by the British Society of Immunology in March 2016, more than 80 autoimmune diseases have been identified. Furthermore, increasing investments by governments and industries, rising biotechnology research across the globe, and growing awareness about personalized therapeutics is fueling the market growth.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7816
However, the presence of alternative technologies for protein purification may negatively affect market growth during the forecast period.
The global immunoprecipitation market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2018, Abcam plc entered into a strategic agreement with F. Hoffmann-La Roche Ltd, a leading biotech company, under which Abcam received the exclusive rights to the product portfolio of Spring, that consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products.
Regional Analysis
Americas is anticipated to dominate the global immunoprecipitation market owing to the increasing research activities and the presence of major market players. Additionally, the well-developed healthcare sector is anticipated to boost the immunoprecipitation market in the region.
Europe is expected to hold the second largest position in the global immunoprecipitation market. The market growth in this region is attributed to the availability of funds for research.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the growing investment from governments, growing biotechnology research in these regions, and raising awareness about personalized therapeutics.
On the other hand, the Middle East & Africa is expected to account for the least share of the market.
Segmentation
The global immunoprecipitation market has been segmented into type, product, end-user, and region.
The market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.
The market, by type, has been segmented into kit, reagent, and others.
The market, based on reagent, has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers.
The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.
Key Players
Some of the key players in the global immunoprecipitation market are Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Merck KGaA, BioLegend, Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology, Inc., Geno Technology Inc.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/immunoprecipitation-market-7816
No comments:
Post a Comment